Cure of Apparent Mineralocorticoid Excess by Kidney Transplantation

Authors:
  • MPMario Palermo
    Mario Palermo
  • MCMaria Cossu
    Maria Cossu
  • CSCedric H.L. Shackleton
    Cedric H.L. Shackleton

Abstract
Kidney 11β-hydroxysteroid dehydrogenase 2 protects against mineralocorticoid excess by oxidatively converting cortisol, which binds to mineralocorticoid receptors as well as does aldosterone, to cortisone. Loss-of-function mutations in the gene for this enzyme cause the syndrome of apparent mineralocorticoid excess, with severe hypertension and hypokalemia.1,2 Most patients with the syndrome can be treated effectively with mineralocorticoid-receptor antagonists, potassium-sparing diuretics, and dexamethasone. We describe a woman with apparent mineralocorticoid excess who was cured by renal transplantation.

This publication has 4 references indexed in Scilit: